Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 1/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.67 |
| ▸ | LTA4H | P09960 | 5/20 | 0.60 |
| ▸ | ESR1 | P03372 | 8/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.53 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.52 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.52 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7581591 | 0.91 | LTA4H (0.61) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL8003918 | 0.90 | LTA4H (0.60) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL7571695 | 0.90 | LTA4H (0.62) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL8015672 | 0.86 | EBP (0.88) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL6595246 | 0.85 | LTA4H (0.59) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL8504413 | 0.84 | EBP (0.64) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL7580135 | 0.84 | ESR1 (0.67) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL7582532 | 0.83 | ESR1 (0.65) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL3863139 | 0.82 | ESR1 (0.78) | EBPSIGMAR1LTA4HESR1ESR2 | |
| SCHEMBL13897604 | 0.82 | ESR1 (0.78) | EBPSIGMAR1LTA4HESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6114336-A | Cosmetic composition containing a neuropeptide Y receptor antagonist | SANOFI (FR) | 2000-09-05 | — | — | US | disclosed |